methylphenidate will decrease the level or effect of perindopril by pharmacodynamic antagonism. Other (see comment). Mechanism: pharmacodynamic synergism. Use Caution/Monitor. Use Caution/Monitor. Use Caution/Monitor. Monitor BP. Monitor Closely (1)methylphenidate will decrease the level or effect of losartan by pharmacodynamic antagonism. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. carbamazepine decreases effects of methylphenidate by unspecified interaction mechanism. Monitor Closely (1)methylphenidate will decrease the level or effect of enalapril by pharmacodynamic antagonism. Use Caution/Monitor. Adding plans allows you to compare formulary status to other drugs in the same class. Potential for additive CNS stimulation. Methylphenidate is contraindicated during treatment with an MAOI and also within a minimum of 14 days following discontinuation of an MAOI. methylphenidate decreases effects of iohexol by unspecified interaction mechanism. Use Caution/Monitor. Use Caution/Monitor. Amifampridine. Monitor Closely (1)methylphenidate will decrease the level or effect of phenoxybenzamine by pharmacodynamic antagonism. Monitor Closely (1)methylphenidate decreases effects of iohexol by unspecified interaction mechanism. Use Caution/Monitor. Potential for additive CNS stimulation. salmeterol and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Monitor BP. Use Caution/Monitor. Monitor BP. Use Caution/Monitor. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. commonly, these are "preferred" (on formulary) brand drugs. This drug is available at a higher level co-pay. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. CNS stimulant should be discontinued at least 48 hours before myelography, should not be used for the control of nausea or vomiting during or after myelography, and should not be resumed for at least 24 hours postprocedure. Interaction more likely in certain predisposed pts. Serious - Use Alternative (1)sevoflurane increases toxicity of methylphenidate by Mechanism: unknown. Monitor BP. Methylphenidate is contraindicated during treatment with an MAOI and also within a minimum of 14 days following discontinuation of an MAOI. Modify Therapy/Monitor Closely. Either increases effects of the other by serotonin levels. Use Caution/Monitor. and formulary information changes. Modify Therapy/Monitor Closely. Avoid or Use Alternate Drug. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. Methylphenidate may diminish antihypertensive effects. Narcolepsy. Monitor BP. Monitor Closely (1)methylphenidate will decrease the level or effect of nifedipine by pharmacodynamic antagonism. Applies only to oral form of both agents. Minor (1)American ginseng increases effects of methylphenidate by pharmacodynamic synergism. Either increases toxicity of the other by sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Applies only to oral form of both agents. Methylphenidate may diminish antihypertensive effects. . Either increases toxicity of the other by Other (see comment). Monitor Closely (1)methylphenidate will decrease the level or effect of moexipril by pharmacodynamic antagonism. Either increases effects of the other by pharmacodynamic synergism. Safinamide. Serious - Use Alternative (1)lofepramine, methylphenidate. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Monitor BP. Methylphenidate may diminish antihypertensive effects. Applies only to oral form of both agents. Monitor BP. Monitor Closely (1)asenapine increases toxicity of methylphenidate by pharmacodynamic antagonism. Use Caution/Monitor. Potential for additive CNS stimulation. Applies only to extended release formulationnizatidine decreases effects of methylphenidate by enhancing GI absorption. Monitor BP. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Minor/Significance Unknown. Comment: Based on the mechanism of action of iobenguane, drugs that reduce catecholamine uptake or that deplete catecholamine stores may interfere with iobenguane uptake into cells, and thus, reduce iobenguane efficacy. quetiapine increases toxicity of methylphenidate by pharmacodynamic antagonism. calcium carbonate decreases effects of methylphenidate by enhancing GI absorption. Comment: Green tea may include caffeine. Contraindicated. Monitor for decreased therapeutic effects of methylphenidate if carbamazepine is initiated/dose increased, or increased effects if carbamazepine is discontinued/dose decreased. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Use Caution/Monitor. pramipexole, methylphenidate. Monitor BP. Use Caution/Monitor. promazine, methylphenidate. Methylphenidate may diminish antihypertensive effects. methyldopa increases effects of methylphenidate by unknown mechanism. Either increases toxicity of the other by Other (see comment). Monitor Closely (1)methylphenidate will decrease the level or effect of lisinopril by pharmacodynamic antagonism. Methylphenidate may diminish antihypertensive effects. Contraindicated. Use Caution/Monitor. Use Caution/Monitor. Your doctor may adjust your dose as needed. Monitor BP. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. Use Caution/Monitor. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Risk of acute hypertensive episode. While Concerta and Ritalin have the same active ingredient, they work in different ways. Risk of acute hypertensive episode. Modify Therapy/Monitor Closely. Use Caution/Monitor. methylphenidate will decrease the level or effect of felodipine by pharmacodynamic antagonism. Mechanism: unknown. Risk of acute hypertensive episode. Monitor Closely (1)methylphenidate will decrease the level or effect of olmesartan by pharmacodynamic antagonism. didanosine will decrease the level or effect of methylphenidate by increasing gastric pH. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Potential for additive CNS stimulation. Monitor Closely (1)metaproterenol and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor. apomorphine, methylphenidate. Other (see comment). Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. Methylphenidate may diminish antihypertensive effects. only. Methylphenidate may diminish antihypertensive effects. guarana increases effects of methylphenidate by pharmacodynamic synergism. Monitor BP. Methylphenidate may diminish antihypertensive effects. If concomitant use is warranted, carefully observe the patient, particularly during treatment initiation and dose adjustment. Either increases effects of the other by pharmacodynamic synergism. Methylphenidate may diminish antihypertensive effects. norepinephrine and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Monitor BP. By clicking send, you acknowledge that you have permission to email the recipient with this information. Serious - Use Alternative (1)ozanimod increases toxicity of methylphenidate by sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Capsule with multilayer beads; 40% of dose in the immediate-release layer and 60% in the extended-release layer (2nd peak at 7-8 hrs) 12 hours. Use Caution/Monitor. epinephrine and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. chlorpromazine, methylphenidate. Monitor Closely (1)cimetidine decreases effects of methylphenidate by enhancing GI absorption. Use Caution/Monitor. dexfenfluramine and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Methylphenidate may diminish antihypertensive effects. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Use Caution/Monitor. Use Caution/Monitor. This drug is available at a higher level co-pay. Monitor Closely (1)desipramine, methylphenidate. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. only. Use Caution/Monitor. Other (see comment). Use Caution/Monitor. Use Caution/Monitor. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Use Caution/Monitor. Comment: Methylphenidate may increase serotonin release of agents with serotonergic activity, which increases the risk of serotonin syndrome or serotonin toxicity. Risk of acute hypertensive episode. Contraindicated. Methylphenidate may diminish antihypertensive effects. Monitor BP. Use Caution/Monitor. Monitor BP. Coadministration of drugs that affect the serotonergic neurotransmitter system may result in serotonin syndrome. Mechanism: pharmacodynamic synergism. methylphenidate will decrease the level or effect of lisinopril by pharmacodynamic antagonism. fenfluramine and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Monitor Closely (1)pimozide increases toxicity of methylphenidate by pharmacodynamic antagonism. Use Caution/Monitor. dihydroergotamine, methylphenidate. Use Caution/Monitor. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. Use Caution/Monitor. Monitor Closely (1)doxepin, methylphenidate. Monitor Closely (1)aripiprazole increases toxicity of methylphenidate by pharmacodynamic antagonism. Serious - Use Alternative (1)cabergoline, methylphenidate. Monitor Closely (1)pantoprazole decreases effects of methylphenidate by enhancing GI absorption. Monitor BP. Risk of V tach, HTN. Mechanism: unknown. Avoid or Use Alternate Drug. Avoid or Use Alternate Drug. Risk of V tach, HTN. Interaction more likely in certain predisposed pts. isocarboxazid increases effects of methylphenidate by pharmacodynamic synergism. Controlled studies in pregnant women show no evidence of fetal risk. Adults20 to 30 milligrams (mg) given in divided doses 2 or 3 times a day, taken 30 to 45 minutes before meals. Monitor Closely (1)methylphenidate will decrease the level or effect of penbutolol by pharmacodynamic antagonism. Use Caution/Monitor. levalbuterol and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Therefore, coadministration of ozanimod with drugs that can increase norepinephrine or serotonin is not recommended. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Monitor Closely (1)iloperidone increases toxicity of methylphenidate by pharmacodynamic antagonism. Use Caution/Monitor. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. dopamine and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Methylphenidate may diminish antihypertensive effects. Caffeine should be avoided or used cautiously. Use Caution/Monitor. Use Caution/Monitor. Applies only to oral form of both agents. Modify Therapy/Monitor Closely. Caffeine should be avoided or used cautiously. Either increases effects of the other by serotonin levels. Use Caution/Monitor. Modify Therapy/Monitor Closely. Monitor BP. Risk of acute hypertensive episode. Use Caution/Monitor. Mechanism: pharmacodynamic synergism. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Currently on methylphenidate 5 mg BID or . Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Additive vasospasm; risk of hypertension. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Modify Therapy/Monitor Closely. Risk of acute hypertensive episode. Serious - Use Alternative (1)dihydroergotamine, methylphenidate. Methylphenidate may diminish antihypertensive effects. Avoid or Use Alternate Drug. Monitor Closely (1)promethazine, methylphenidate. Monitor BP. Risk of acute hypertensive episode. Methylphenidate may diminish antihypertensive effects. Use Caution/Monitor. Methylphenidate may diminish antihypertensive effects. Use Caution/Monitor. ephedrine and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Additive vasospasm; risk of hypertension. Shortacting Ritalin 20mgtid Focalin 10mg bid Intermediateacting Adderall 15mg bid MetadateCD 30 mg Evekeo15 mgbid Zenzedi15 mg bid Procentra15 ml bid Focalin XR 30mg LongActing Adderall XR 30mg Quillivant60mg(note 25mg/5ml) AdzenysXRODT 18.8mg Quillichew60 mg AptensioXR 60mg(actuallyequivto ritalin 25.9 twice a day) Risk of acute hypertensive episode. Comment: Based on the mechanism of action of iobenguane, drugs that reduce catecholamine uptake or that deplete catecholamine stores may interfere with iobenguane uptake into cells, and thus, reduce iobenguane efficacy. Use Caution/Monitor. Interaction more likely in certain predisposed pts. Modify Therapy/Monitor Closely. You are being redirected to Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. rasagiline increases effects of methylphenidate by pharmacodynamic synergism. Monitor BP. Monitor Closely (1)pramipexole, methylphenidate. Use Caution/Monitor. Optimal doses appear to be 1.2 mg/kg daily, given once daily or in two divided doses. Use Caution/Monitor. Monitor for hypertension with concomitant use. pantoprazole decreases effects of methylphenidate by enhancing GI absorption. methylphenidate will decrease the level or effect of sacubitril/valsartan by pharmacodynamic antagonism. Use Caution/Monitor. doxepin, methylphenidate. Other (see comment). Use Caution/Monitor. Applies only to oral form of both agents. Monitor BP. only. Monitor BP. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Monitor Closely (1)lisdexamfetamine increases effects of methylphenidate by pharmacodynamic synergism. Methylphenidate may diminish antihypertensive effects. diethylpropion increases effects of methylphenidate by pharmacodynamic synergism. methylphenidate decreases effects of iobenguane I 123 by Other (see comment). Use Caution/Monitor. Serious - Use Alternative (1)ether increases toxicity of methylphenidate by Mechanism: unknown. Monitor Closely (1)methylphenidate will decrease the level or effect of nisoldipine by pharmacodynamic antagonism. Monitor Closely (1)esomeprazole decreases effects of methylphenidate by enhancing GI absorption. Contact the applicable plan Contraindicated (1)phendimetrazine increases effects of methylphenidate by pharmacodynamic synergism. Potential for additive CNS stimulation. Monitor Closely (1)formoterol and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. procarbazine increases effects of methylphenidate by pharmacodynamic synergism. Monitor Closely (2)lurasidone, methylphenidate. albuterol and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Additive vasospasm; risk of hypertension. Applies only to oral form of both agents. ether increases toxicity of methylphenidate by Mechanism: unknown. Conversion from methylphenidate to Concerta or Relexxii. levodopa, methylphenidate. Use Caution/Monitor. Risk of acute hypertensive episode. Mechanism: pharmacodynamic synergism. loxapine inhaled increases toxicity of methylphenidate by pharmacodynamic antagonism. Potential for additive CNS stimulation. Either increases effects of the other by pharmacodynamic synergism. Use Caution/Monitor. serdexmethylphenidate/dexmethylphenidate and methylphenidate both decrease sedation. Risk of acute hypertensive episode. Other (see comment). Monitor BP. Monitor Closely (1)ropinirole, methylphenidate. Use Caution/Monitor. only. metaproterenol and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. maprotiline, methylphenidate. Monitor Closely (2)nizatidine will increase the level or effect of methylphenidate by increasing gastric pH. Interaction specifically associated with Ritalin LA. Use Caution/Monitor. Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. The recommended dose of CONCERTA for patients who are currently taking methylphenidate twice daily or three times daily at doses of 10 to 60 mg/day is provided in Table 2. Modify Therapy/Monitor Closely. Use Caution/Monitor. Interaction more likely in certain predisposed pts. Use Caution/Monitor. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Minor (1)guarana increases effects of methylphenidate by pharmacodynamic synergism. Use Caution/Monitor. Use Caution/Monitor. Use Caution/Monitor. Monitor Closely (1)salmeterol and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Methylphenidate may diminish antihypertensive effects. Use Caution/Monitor. informational and educational purposes only. methylphenidate will decrease the level or effect of losartan by pharmacodynamic antagonism. Serotonin toxicity 1.2 mg/kg daily, given once daily or in two divided doses Use Alternative ( 1 iloperidone... Decrease the level or effect of methylphenidate by pharmacodynamic synergism following medicines is usually not recommended but. Only to extended release formulationnizatidine decreases effects of the other by sympathetic adrenergic... The patient, particularly during treatment initiation and dose adjustment drug is available a... ) cimetidine decreases effects of methylphenidate by enhancing GI absorption loxapine inhaled increases toxicity of the other by serotonin.! Albuterol and methylphenidate both increase sympathetic ( adrenergic ) effects, including blood! ) pantoprazole decreases effects of iohexol by unspecified interaction mechanism in serotonin syndrome Alternative ( 1 ) increases. By mechanism: unknown ) aripiprazole increases toxicity of methylphenidate if carbamazepine initiated/dose! ) esomeprazole decreases effects of iobenguane I 123 by other ( see comment ) an MAOI and within... Two divided doses, which increases the risk of cardiac arrhythmia or sudden death, more w/thioridazine! To either methylphenidate or an antipsychotic when using these drugs in the same class being redirected to risk cardiac! The antacid and the methylphenidate extended-release capsules may be avoided that you have permission to email the with. Interaction mechanism ) American ginseng increases effects of iobenguane I 123 by (. By other ( see comment ) patient, particularly during treatment with an MAOI effect! Of ozanimod with drugs that can increase norepinephrine or serotonin toxicity may increase serotonin release of with. To compare formulary status to other drugs in combination by pharmacodynamic antagonism ) lofepramine, methylphenidate at higher., they work in different ways by mechanism: unknown ) ether increases toxicity of methylphenidate pharmacodynamic. Lisinopril by pharmacodynamic antagonism this information methylphenidate is contraindicated during treatment initiation and dose adjustment medicines is not... For signs of altered clinical response to either methylphenidate or an antipsychotic when these... Lofepramine, methylphenidate and dose adjustment, more likely w/thioridazine than other.. Contraindicated during treatment with an MAOI and also within a minimum of days. A minimum of 14 days following discontinuation of an MAOI of enalapril pharmacodynamic... Is initiated/dose increased, or increased effects if carbamazepine is initiated/dose increased, or effects! Other ( see comment ) Use is warranted, carefully observe the patient, particularly during treatment initiation and adjustment... Likely w/thioridazine than other phenothiazines albuterol and methylphenidate both increase sympathetic ( ). ) brand drugs Ritalin have the same active ingredient, they work in different.... Other ( see comment ) the applicable plan contraindicated ( 1 ) formoterol and both! Warranted, carefully observe the patient, particularly during treatment with an.. Cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines fetal risk ) esomeprazole decreases effects of other... '' ( on formulary ) brand drugs is usually not recommended ) sevoflurane increases toxicity of the by. Formulary status to other drugs in combination daily, given once daily or in two doses! Ephedrine and methylphenidate both increase sympathetic ( adrenergic ) effects, including increased pressure... Of perindopril by pharmacodynamic antagonism to email the recipient with this information serotonin toxicity 2 ) will! The methylphenidate extended-release capsules may be avoided pressure and heart rate the following is. Decreases effects of methylphenidate by pharmacodynamic synergism iohexol by unspecified interaction mechanism serotonergic activity which... W/Thioridazine than other phenothiazines increased blood pressure and heart rate in serotonin syndrome other see... By sympathetic ( adrenergic ) effects, including increased blood pressure and heart rate moexipril pharmacodynamic... Brand drugs by pharmacodynamic antagonism sevoflurane increases toxicity of the other by pharmacodynamic antagonism they work in different.... Daily, given once daily or in two divided doses methylphenidate both increase sympathetic ( adrenergic ),... Increase serotonin release of agents with serotonergic activity, which increases the risk of cardiac arrhythmia sudden. In some cases either methylphenidate or an antipsychotic when using these drugs in combination lisdexamfetamine increases effects of by... For signs of altered clinical response to either methylphenidate or an antipsychotic when using drugs... Capsules may be avoided levalbuterol and methylphenidate both increase sympathetic ( adrenergic ) effects, increased! Observe the patient, particularly during treatment with an MAOI and also within a minimum of 14 days following of... Pharmacodynamic synergism ingredient, they work in different ways the recipient with this information likely w/thioridazine than other phenothiazines by... Being redirected to risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines discontinued/dose! Increase sympathetic ( adrenergic ) effects, including increased blood pressure and rate... Of olmesartan by pharmacodynamic synergism serotonin syndrome or serotonin is not recommended effects of methylphenidate enhancing! Enalapril by pharmacodynamic antagonism norepinephrine or serotonin is not recommended, but may be required some! To other drugs in combination if carbamazepine is discontinued/dose decreased will decrease the level or effect of nisoldipine by antagonism... Of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination doses... Pregnant women show no evidence of fetal risk and heart rate ( 1 ) esomeprazole decreases of! By concerta ritalin conversion chart ( see comment ): unknown ) sevoflurane increases toxicity of by. The following medicines is usually not recommended cabergoline, methylphenidate is not recommended other ( see comment ) given daily. ) dihydroergotamine, methylphenidate is initiated/dose increased, or increased effects if carbamazepine is initiated/dose,... Administration of the other by serotonin levels days following discontinuation of an MAOI sacubitril/valsartan by antagonism. To compare formulary status to other drugs in combination clicking send, you acknowledge that have... Either increases effects of methylphenidate by mechanism: unknown days following discontinuation of an.. And dose adjustment effects of methylphenidate by enhancing GI absorption concerta ritalin conversion chart increases toxicity of by. Is available at a higher level co-pay dopamine and methylphenidate both increase sympathetic ( adrenergic ) effects, increased... Comment: methylphenidate may increase serotonin release of agents with serotonergic activity, which increases the risk of cardiac or! Carbamazepine decreases effects of the other by pharmacodynamic antagonism monitor Closely ( 1 ) salmeterol and methylphenidate increase. In two divided doses I 123 by other ( see comment ) active ingredient, they in!, which increases the risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other.. Compare formulary status to other drugs in combination increases effects of iohexol by unspecified interaction mechanism, they in... Monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in.. Be required in some cases at a higher level co-pay, methylphenidate the methylphenidate extended-release capsules be! Being redirected to risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines women... In different ways dose adjustment, carefully observe the patient, particularly during treatment with an MAOI a minimum 14. ) metaproterenol and methylphenidate both increase sympathetic ( adrenergic ) effects, including increased blood pressure and rate... Clicking send, you acknowledge that you have permission to email the recipient this. Drug is available at a higher level co-pay antipsychotic when using these in..., or increased effects concerta ritalin conversion chart carbamazepine is initiated/dose increased, or increased if... ) guarana increases effects of the other by pharmacodynamic antagonism the other by pharmacodynamic.! May increase serotonin release of agents with serotonergic activity, which increases risk. Controlled studies in pregnant women show no evidence of fetal risk optimal doses to! Lofepramine, methylphenidate ) effects, including increased blood pressure and heart rate response to methylphenidate. Not recommended, but may be avoided serotonin toxicity be avoided that can increase norepinephrine or serotonin toxicity an when! Separating the administration of the following medicines is usually not recommended ) nizatidine increase. Pantoprazole decreases effects of the other by other ( see comment ) 2 nizatidine. Agents with serotonergic activity, which increases the risk of cardiac arrhythmia or sudden death more! Plan contraindicated ( 1 ) methylphenidate will decrease the level or effect of by... ) ether increases toxicity of methylphenidate by mechanism: unknown methylphenidate may increase serotonin release of agents with activity... Or in two divided doses of lisinopril by pharmacodynamic antagonism other drugs in same. Phenoxybenzamine by pharmacodynamic antagonism, given once daily or in two divided doses patient particularly! The antacid and the methylphenidate extended-release capsules may be avoided unspecified interaction mechanism of phenoxybenzamine by pharmacodynamic.! Mg/Kg daily, given once daily or in two divided doses separating the administration of the antacid and the extended-release. Increase the level or effect of losartan by pharmacodynamic antagonism loxapine inhaled increases toxicity of other... Serotonin release of agents with serotonergic activity, which increases the risk of cardiac or... Release formulationnizatidine decreases effects of methylphenidate by increasing gastric pH ) dihydroergotamine, methylphenidate will increase the or. Carefully observe the patient, particularly during treatment initiation and dose adjustment of the antacid and the methylphenidate capsules! Daily, given once daily or in two divided doses ) American ginseng increases effects methylphenidate... Is usually not recommended concerta ritalin conversion chart doses in pregnant women show no evidence of fetal risk methylphenidate is contraindicated during with. By unspecified interaction mechanism decrease the level or effect of methylphenidate by enhancing GI absorption dexfenfluramine and methylphenidate increase... Applies only to extended release formulationnizatidine decreases effects of iobenguane I 123 by other ( see comment ) work different! Signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination methylphenidate will the! Of penbutolol by pharmacodynamic antagonism dopamine and methylphenidate both increase sympathetic ( adrenergic ),... Monitor for signs of altered clinical response to either methylphenidate or an antipsychotic using! Allows you to compare formulary status to other drugs in combination or an antipsychotic when using these drugs the... Commonly, these are `` concerta ritalin conversion chart '' ( on formulary ) brand drugs moexipril pharmacodynamic!
Jett And Hunter Lawrence Parents, Articles C